Cancer, cardiovascular disease (CVD), and diabetes are life-threatening diseases that are among the primary causes of the majority of deaths in the world. Epigenetics is the solution chosen by the biologists to reduce the death rate on a faster basis. IndustryARC’s recent publication reveals that the global epigenetics market size marked $1.15 billion in 2018, and the demand is set to grow at a progressive compound annual growth rate (CAGR) of 13.20% during the forecast period of 2019 to 2025. This report covers Epigenetics market Size by Product and applications, Epigenetics market share by top 5 companies and also the market share by start-ups during the forecast period.
The report is titled: “Epigenetics Market: By Products (Kits, Reagents, Enzymes, Others), By Application (Diagnostics, Drugs, Others), By End Users (Research Institutes, Diagnostic Centers, Others) & Geography – Forecast (2019 - 2025).” It provides a thorough analysis of competitive structure, the market shares of the competitors, market trends, market demands, market drivers, market challenges, and product analysis to the key market participants with the necessary business intelligence that can help them understand the future of the global epigenetics market.
View Full Table of Contents @ https://www.industryarc.com/Report/10610/epigenetics-market.html
Epigenetics Market: Leading Segments
Epigenetics has several potential medical applications. It is capable enough to explain the mechanism of human development, heart disease, aging, the origins of cancer, and mental illness as well. New avenues created through several epigenetics studies in this region determined the share of North America in the global epigenetics market. On November 2017, The American Diabetes Association organized a research symposium, namely “Epigenetics and Epigenomics: Implications for Diabetes and Obesity.” In this symposium, the organization revealed that epigenetics regulate the metabolism and the risk associated with diabetes. Furthermore, the analyst found that North America stood as the leading region with its pioneering share of 39% among other regions in the global epigenetics market.
Epigenetics is an emerging field of science which deals with the DNA modifications without any alterations in the DNA sequence that affect gene activity. The services segment is documented as the fastest growing application, that will observe a further increase in revenues at a healthy CAGR of 11.20% during the aforementioned forecast period. Services regarding epigenetics have become the most predominant application in the global epigenetics market because very less number of hospitals are available with their own research unit. Thus, there comes a situation for many hospitals to approach research institutes for epigenetics services, which in return increased the growth opportunities for the services segment in the global epigenetics market.
Epigenetics Market: Disruptive Trends
1) Ground-breaking studies of epigenetics, which are linking cancers of almost all types, respiratory, cognitive dysfunction, cardiovascular, reproductive, autoimmune, and neurobehavioral illnesses with epigenetic mechanisms are boosting the growth of the market.
2) According to the National Center for Biotechnology Information (NCBI), one billion people are anticipated to suffer from metabolic disorders by 2030 on a global basis. Epigenetics plays a prime role in regulating diabetic kidney disease (DKD) and metabolic memory. DKD is regulated through epigenetic mechanisms which include chromatin histone modifications, DNA methylation, and non-coding RNAs as biomarkers and drug targets.
3) Government funds and private investments are evolving the profile of epigenetics through international project launches such as the Human Epigenome Project (HEP).
4) Improvement in the microarray technologies coupled with the developed staining techniques using antibodies is propelling the growth of the epigenetics market.
Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=10610
Epigenetics Market: Competitive Landscape
Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad Laboratories, New England Biolabs, Agilent, QIAGEN, Zymo Research, PerkinElmer, and Diagenode are some of the potential players which are operating in the global epigenetics market.
Related Reports:
A. Genomics Market
https://www.industryarc.com/Report/1275/genomics-market-analysis-and-forecast-report.html
B. Gene Therapy Market
https://www.industryarc.com/Report/15868/gene-therapy-market.html
About IndustryARC:
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business.
